Dr. Ho, Chief Operating Officer of Amarex Taiwan, LLC, oversees the organization in accordance with its affiliate, Amarex Clinical Research (USA). She is responsible for the management of Amarex Taiwan, including clinical operations, business development, and client services for the Pan Pacific region. Dr. Ho has trained under Amarex regulatory experts in the US as a Regulatory Specialist, with the purpose of creating FDA approval strategies for small molecule drugs, biologics, botanicals, and devices within a wide range of therapeutic indications.